There are many reasons to be skeptical of the obesity paradox, but the UCLA researchers have posed some biological explanations for it [source: Kalantar-Zadeh].
- In both CHF and chronic kidney disease, malnutrition and inflammation are common. These conditions alone could reduce the survival of these patients. Therefore, weight gain could be an indicator of better nutrition and, therefore, improved chances of survival in obese patients.
Dr. Kalantar-Zadeh argues that dietary restrictions placed on CHF and chronic kidney disease patients my actually be harmful to these patients. He advocates a "reverse epidemiology" approach to these conditions.
So, the obesity paradox has been observed in several clinical settings (CHF, chronic kidney disease), but physicians and scientists still aren't sure that it's a real phenomenon. Not many researchers have proposed biological hypotheses to explain the obesity paradox. There have been no direct animal studies or clinical trials that could address cause-and-
effect relationships. So, based on evidence available at this time, we can't conclude that the obesity paradox is real, certainly not enough to alter treatment for patients with CHF and chronic kidney disease. But many scientists think that research should be aimed at resolving the obesity paradox. It may have implications for changing treatment options for these patients.
Dr. Kalantar-Zadeh and colleagues also argue that the risk factors for the general population may not be applicable to the obese population. The obesity paradox is one example of this idea, which has been called reverse epidemiology. Imposing dietary restrictions on obese chronic disease patients, they say, may actually be harmful. The group cites a number of conditions where phenomena like the obesity paradox have been observed [source: Kalantar-Zadeh].
For more information on the obesity paradox, check out the links below.
Related HowStuffWorks Articles
More Great Links
- Bray, GA, Medical consequences of obesity, JCEM: 89: 2583-2589, 2004. http://jcem.endojournals.org/cgi/content/full/89/6/2583
- Cordtlandt Forum: Extra weight: A benefit for some patients? http://www.cortlandtforum.com/content/index.php?id=26&no_cache=1&tx_cortlandtmagissue_pi1%5BshowUid%5D=1489InCites
- Cossrow, N and B Falkner, Race/ethnic issues in obesity and obesity-related comorbidities, JCEM: 89: 2590-2594, 2004. http://jcem.endojournals.org/cgi/content/full/89/6/2590
- Davey Smith, G et al, Meta-analysis: Beyond the Grand Mean?, British Medical Journal: 315:1610-1614, 1997. http://www.bmj.com/cgi/content/full/315/7122/1610
- Egger, M AND G Davey Smith, Meta-analysis: Potentials and Promise, British Medical Journal: 315:1371-1374, 1997. http://www.bmj.com/cgi/content/full/315/7119/1371
- Egger, M et al, Meta-analysis: Principles and Procedures, British Medical Journal: 315:1533-1537, 1997. http://www.bmj.com/cgi/content/full/315/7121/1533
- Habbu, A et al, The Obesity Paradox: Fact or Fiction?, Am J Cardiol 98: 944-948, 2004. http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=16996880&dopt=Citation
- Hall JA et al, The Paradox of Obesity in Patients with Heart Failure, Journal of the American Academy of Nurse Practitioners 17, 542-546, 2005. http://www.blackwell-synergy.com/doi/abs/10.1111/j.1745-7599.2005.00084.x?journalCode=jaan
- InCites: An Interview with Dr. Kamyar Kalantar-Zadeh. http://in-cites.com/scientists/KamyarKalantar-Zadeh.html
- Kalantar-Zadeh, K et a. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients, Kidney International 63: 793-808, 2003. http://www.nephrology.rei.edu/RevEpi_01.pdf
- Kalantar-Zadeh, K et al, Racial and survival paradoxes in chronic kidney disease, Nature Clinical Practice Nephrology 3, 493-506, 2007. http://npg.nature.com/ncpneph/journal/v3/n9/full/ncpneph0570.html;jsessionid=9D829C9B81FD63FE14FE8385A996A823
- Kopple, JD, The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure, American Journal of Clinical Nutrition 81: 1257-1266, 2005. http://www.ajcn.org/cgi/content/full/81/6/1257?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&searchid=1&FIRSTINDEX=0&minscore=5000&resourcetype=HWCIT
- Liu, Y et al, Association Between Cholesterol Level and Mortality in Dialysis Patients, JAMA; 291: 451-459, 2004. http://jama.ama-assn.org/cgi/content/full/291/4/451
- Mosterd, A et al, The Prognosis of Heart Failure in the General Population: The Rotterdam Study, European Heart Journal 22, 1318-1327, 2001. http://eurheartj.oxfordjournals.org/cgi/reprint/22/15/1318
- NHLBI/NIH, Guidelines on Overweight and Obesity: Electronic Textbook. http://www.nhlbi.nih.gov/guidelines/obesity/e_txtbk/txgd/4142.htm
- NIDDK/NIH Weight-control Information network, Understanding Adult Obesity. http://win.niddk.nih.gov/publications/understanding.htm
- Romero-Coral, A et al, Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease, European Heart Journal 28: 2087-2093, 2007. http://eurheartj.oxfordjournals.org/cgi/content/abstract/28/17/2087
- Ryan, D, Risks and benefits of weight loss: challenges to obesity research, European Heart Journal Supplements 7 (Supplement L), L27-L31, 2005. http://eurheartjsupp.oxfordjournals.org/cgi/content/full/7/suppl_L/L27
- Slyper, AH, The pediatric obesity epidemic: causes and controversies, JCEM: 89: 2540-2547, 2004. http://jcem.endojournals.org/cgi/content/full/89/6/2540
- Special Obesity Issue, Journal of Endocrinology and Metabolism (JCEM): 89, June, 2004. http://jcem.endojournals.org/content/vol89/issue6/
- Stein, CJ and GA Colidtz, GA, The epidemic of obesity, JCEM: 89: 2522-2525, 2004. http://jcem.endojournals.org/cgi/content/full/89/6/2522